Cancer Survivor Story: My Successful Targeted Therapy Treatment | Ashley's Story (2 of 3)

In this segment, Ashley shares how she was able to land on a newly FDA-approved targeted treatment (osimertinib or Tagrisso) that allowed her to skip chemotherapy through an IV at the hospital and instead, take a daily pill. She shares how she was able to get such a new drug approved through her insurance, her follow-up schedule with her oncologist, and delves also into the side effects and how she’s been able to get through them as best as she can every day.
Navigation → see below for time codes to different subsections.

In this Series: Our 3-part series with Ashley covers her from how she got diagnosed, to the targeted therapy that had just been approved for her cancer subtype and genetic mutation (EGFR+ T790M) that allowed her to take a pill (osimertinib or Tagrisso) instead of traditional chemotherapy, through how she lives with her incurable but treatable disease.

Full story & transcript →https://www.thepatientstory.com/patie...

The interview has only been edited for clarity.

Join Our Community:
Website : https://www.thepatientstory.com/
Facebook: @ThePatientStory
Instagram: @ThePatientStory
Twitter: @patient_story
______________________________

Contents of this video:
0:00 - Intro: Treatment & Testing
0:57 - Describe the scan of your lungs
1:59 - Deciding where to get treatment
4:48 - The Genomic Testing
11:42 - Targeted Therapy (osimertinib) Schedule
13:07 - Dealing with side effects
21:45 - Giving yourself Grace
25:28 - Experience of brand new treatment
31:49 - Monitoring schedule with oncologist

______________________________

#LungCancer #Cancer #ThePatientStory
#egfr #genomictesting #clinicaltrials #targetedtherapy #osimertinib #tagrisso #astrazeneca